astronics - ATRO
ATRO
Close Chg Chg %
75.60 -2.11 -2.79%
Closed Market
73.49
-2.11 (2.79%)
Volume: 545.23K
Last Updated:
Sep 10, 2026, 4:00 PM EDT
Company Overview: astronics - ATRO
ATRO Key Data
| Open $74.40 | Day Range 72.55 - 75.37 |
| 52 Week Range 39.14 - 99.89 | Market Cap $3.27B |
| Shares Outstanding 43.01M | Public Float 35.22M |
| Beta 1.19 | Rev. Per Employee N/A |
| P/E Ratio 40.27 | EPS $2.12 |
| Yield 0.00% | Dividend $19.40 |
| EX-DIVIDEND DATE Jun 15, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 678.10K |
ATRO Performance
| 1 Week | -0.87% | ||
| 1 Month | -18.73% | ||
| 3 Months | -21.25% | ||
| 1 Year | 89.52% | ||
| 5 Years | 473.16% |
ATRO Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
4
Full Ratings ➔
About astronics - ATRO
Astronics Corp. engages in the provision of electrical power generation and distribution systems. The firm includes motion systems, lighting and safety systems, avionics products, aircraft structures, systems certification, and automated test systems. It operates through the Aerospace and Test Systems segments. The Aerospace segment designs and manufactures products for the global aerospace industry. The Test Systems segment designs, develops, manufactures and maintains communications and weapons test systems and training and simulation devices for military applications. The company was founded in 1968 and is headquartered in East Aurora, NY.
ATRO At a Glance
Astronics Corp.
130 Commerce Way
East Aurora, New York 14052-2191
| Phone | 1-716-805-1599 | Revenue | 862.13M | |
| Industry | Aerospace & Defense | Net Income | 29.36M | |
| Sector | Electronic Technology | 2025 Sales Growth | 8.386% | |
| Fiscal Year-end | 12 / 2026 | Employees | 2,700 | |
| View SEC Filings |
ATRO Valuation
| P/E Current | 40.271 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 67.362 |
| Price to Sales Ratio | 2.294 |
| Price to Book Ratio | 12.751 |
| Price to Cash Flow Ratio | 26.44 |
| Enterprise Value to EBITDA | 23.796 |
| Enterprise Value to Sales | 2.712 |
| Total Debt to Enterprise Value | 0.162 |
ATRO Efficiency
| Revenue/Employee | 319,306.667 |
| Income Per Employee | 10,873.704 |
| Receivables Turnover | 4.212 |
| Total Asset Turnover | 1.243 |
ATRO Liquidity
| Current Ratio | 3.098 |
| Quick Ratio | 1.705 |
| Cash Ratio | 0.129 |
ATRO Profitability
| Gross Margin | 29.944 |
| Operating Margin | 8.863 |
| Pretax Margin | 3.705 |
| Net Margin | 3.405 |
| Return on Assets | 4.234 |
| Return on Equity | 14.821 |
| Return on Total Capital | 5.663 |
| Return on Invested Capital | 6.13 |
ATRO Capital Structure
| Total Debt to Total Equity | 270.11 |
| Total Debt to Total Capital | 72.981 |
| Total Debt to Total Assets | 52.206 |
| Long-Term Debt to Equity | 265.968 |
| Long-Term Debt to Total Capital | 71.862 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Astronics - ATRO
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 534.89M | 689.21M | 795.43M | 862.13M | |
Sales Growth
| +20.23% | +28.85% | +15.41% | +8.39% | |
Cost of Goods Sold (COGS) incl D&A
| 421.12M | 514.91M | 574.98M | 603.97M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 27.78M | 26.10M | 24.47M | 21.84M | |
Depreciation
| 12.88M | 12.20M | 11.57M | 10.34M | |
Amortization of Intangibles
| 14.90M | 13.90M | 12.90M | 11.50M | |
COGS Growth
| +38.20% | +22.27% | +11.67% | +5.04% | |
Gross Income
| 113.78M | 174.30M | 220.44M | 258.16M | |
Gross Income Growth
| -18.85% | +53.19% | +26.48% | +17.11% | |
Gross Profit Margin
| +21.27% | +25.29% | +27.71% | +29.94% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 143.75M | 172.74M | 181.54M | 164.72M | |
Research & Development
| 48.30M | 53.50M | 52.10M | 43.48M | |
Other SG&A
| 95.45M | 119.24M | 129.44M | 121.25M | |
SGA Growth
| -19.22% | +20.17% | +5.10% | -9.26% | |
Other Operating Expense
| 2.85M | 8.23M | 12.43M | 17.02M | |
Unusual Expense
| - | (2.78M) | 10.15M | 32.64M | |
EBIT after Unusual Expense
| (30.04M) | (6.67M) | 16.32M | 43.77M | |
Non Operating Income/Expense
| 9.67M | 3.69M | (2.19M) | 738.00K | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | 1.80M | 1.80M | - |
Interest Expense
| 9.42M | 23.33M | 22.00M | 12.56M | |
Interest Expense Growth
| +38.48% | +147.59% | -5.70% | -42.90% | |
Gross Interest Expense
| 9.42M | 23.33M | 22.00M | 12.56M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (29.79M) | (26.31M) | (7.87M) | 31.95M | |
Pretax Income Growth
| -10.51% | +11.69% | +70.10% | +506.06% | |
Pretax Margin
| -5.57% | -3.82% | -0.99% | +3.71% | |
Income Tax
| 5.95M | 110.00K | 8.35M | 2.59M | |
Income Tax - Current - Domestic
| 5.18M | (1.64M) | 7.01M | 2.59M | |
Income Tax - Current - Foreign
| 750.00K | 1.60M | 1.36M | 1.36M | |
Income Tax - Deferred - Domestic
| (126.00K) | 247.00K | (112.00K) | (951.00K) | |
Income Tax - Deferred - Foreign
| 145.00K | (101.00K) | 92.00K | (411.00K) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | 1.80M | 1.80M | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (35.75M) | (26.42M) | (16.21M) | 29.36M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (35.75M) | (26.42M) | (16.21M) | 29.36M | |
Net Income Growth
| -39.76% | +26.09% | +38.63% | +281.06% | |
Net Margin Growth
| -6.68% | -3.83% | -2.04% | +3.41% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (35.75M) | (26.42M) | (16.21M) | 29.36M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (35.75M) | (26.42M) | (16.21M) | 29.36M | |
EPS (Basic)
| -1.1114 | -0.7981 | -0.4628 | 0.8283 | |
EPS (Basic) Growth
| -34.96% | +28.19% | +42.01% | +278.98% | |
Basic Shares Outstanding
| 32.16M | 33.10M | 35.04M | 35.44M | |
EPS (Diluted)
| -1.1114 | -0.7981 | -0.4628 | 0.8052 | |
EPS (Diluted) Growth
| -34.96% | +28.19% | +42.01% | +273.98% | |
Diluted Shares Outstanding
| 32.16M | 33.10M | 35.04M | 36.46M | |
EBITDA
| (5.04M) | 19.43M | 50.93M | 98.25M | |
EBITDA Growth
| +31.80% | +485.19% | +162.09% | +92.90% | |
EBITDA Margin
| -0.94% | +2.82% | +6.40% | +11.40% |
Snapshot
| Average Recommendation | BUY | Average Target Price | 90.042 | |
| Number of Ratings | 4 | Current Quarters Estimate | 0.718 | |
| FY Report Date | 09 / 2026 | Current Year's Estimate | 2.72 | |
| Last Quarter’s Earnings | 0.70 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.604 | Next Fiscal Year Estimate | 3.148 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 4 | 4 | 4 | 4 |
| Mean Estimate | 0.72 | 0.76 | 2.72 | 3.15 |
| High Estimates | 0.78 | 0.81 | 2.89 | 3.48 |
| Low Estimate | 0.64 | 0.70 | 2.52 | 2.80 |
| Coefficient of Variance | 8.24 | 7.04 | 5.92 | 9.31 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 4 | 4 | 4 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 0 | 0 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Astronics - ATRO
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Astronics - ATRO
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 6, 2026 | Peter J. Gundermann PRESIDENT/CEO; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 6, 2026 | James F. Mulato | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 6, 2026 | James F. Mulato | 35,777 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $81.35 per share | 2,910,458.95 |
| Mar 6, 2026 | James F. Mulato | 38,578 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $81.35 per share | 3,138,320.30 |
| Mar 6, 2026 | Mark A. Peabody Executive VP & Pres-Aerospace | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 6, 2026 | Mark A. Peabody Executive VP & Pres-Aerospace | 62,383 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $81.35 per share | 5,074,857.05 |
| Mar 6, 2026 | Mark A. Peabody Executive VP & Pres-Aerospace | 65,025 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $81.35 per share | 5,289,783.75 |
| Mar 6, 2026 | Peter J. Gundermann PRESIDENT/CEO; Director | 93,968 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $81.35 per share | 7,644,296.80 |
| Mar 6, 2026 | Peter J. Gundermann PRESIDENT/CEO; Director | 97,457 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $81.35 per share | 7,928,126.95 |
| Mar 6, 2026 | Nancy L. Hedges Principal Accounting Officer | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 6, 2026 | Nancy L. Hedges Principal Accounting Officer | 32,049 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $81.35 per share | 2,607,186.15 |
| Mar 6, 2026 | Nancy L. Hedges Principal Accounting Officer | 33,870 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $81.35 per share | 2,755,324.50 |
| Mar 3, 2026 | Robert T. Brady Director | 90,602 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $22.93 per share | 2,077,503.86 |
| Mar 3, 2026 | Robert T. Brady Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2026 | Robert T. Brady Director | 89,063 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $78.84 per share | 7,021,726.92 |
| Feb 24, 2026 | James F. Mulato | 7,675 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Dec 4, 2025 | James F. Mulato | 27,078 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $53.24 per share | 1,441,632.72 |
| Dec 4, 2025 | Jeffry D. Frisby Director | 46,523 | Bona fide gift | 0.00 |